In VivoBiopharma merger and acquisition value for the fourth quarter of 2024 reached $9.4bn from 34 transactions, 15 of which had disclosed values. At the top was H. Lundbeck’s $2.6bn purchase of publicly tr
Medtech InsightFDA Panel Strongly Recommends Approval Of Colon Cancer Blood Test The Guardant Health, Inc. Shield, which screens the blood for markers of colon and rectal cancers, got the thumbs up from a US Food
Medtech InsightAxena Health CEO Eileen Maus keeps a sign in her office that reads “Sisu [noun] [Finnish]: The extraordinary and indomitable Finnish spirit to never quit and go beyond all limitations, especially in t
Pink SheetPfizer Inc. ’s commercial during the Super Bowl made a splash, conveying the company’s 175-year history of research in a captivating way without mentioning a particular drug (except for a vintage imag